KALV
KalVista Pharmaceuticals, Inc. Common Stock
$15.21
2.13%
+0.32
Notify me if price changes either direction
Buy KALV stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
769.8M
Enterprise value
731.6M
Trailing PE
-4.1273711496575
Forward PE
-7.1641793
PEG Ratio
-3.7559077461884
Enterprise to EBITDA
-3.625
Enterprise to revenue
513.054
Price to book MRQ
44.642857
Price to sales TTM
531.6931
Financials
Fiscal Year Ends
2025-04-30
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
1.4M
EBITDA
-201820000
Diluted EPS TTM
-3.94
Total Cash (MRQ)
309.2M
Current ratio (MRQ)
5.365
Operating Cash Flow (TTM)
-167188992
KALV trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
December 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
